These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 25906110

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MicroRNA profiles classify papillary renal cell carcinoma subtypes.
    Wach S, Nolte E, Theil A, Stöhr C, T Rau T, Hartmann A, Ekici A, Keck B, Taubert H, Wullich B.
    Br J Cancer; 2013 Aug 06; 109(3):714-22. PubMed ID: 23799849
    [Abstract] [Full Text] [Related]

  • 4. Integrated Analysis Revealed the MicroRNA-Based Prognostic Predicting Signature for Papillary Renal Cell Carcinoma.
    Guan Y, Wang B, Zhang T, Gao S, Cao Z, Zhang M, Liang C.
    DNA Cell Biol; 2021 Mar 06; 40(3):532-542. PubMed ID: 33625263
    [Abstract] [Full Text] [Related]

  • 5. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
    Saleeb RM, Plant P, Tawedrous E, Krizova A, Brimo F, Evans AJ, Wala SJ, Bartlett J, Ding Q, Boles D, Rotando F, Farag M, Yousef GM.
    Eur Urol Focus; 2018 Sep 06; 4(5):740-748. PubMed ID: 28753789
    [Abstract] [Full Text] [Related]

  • 6. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
    Luo L, Zhou H, Su H.
    BMC Cancer; 2021 May 17; 21(1):553. PubMed ID: 33993869
    [Abstract] [Full Text] [Related]

  • 7. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R, Kim SS, Ding Q, Scorilas A, Lin S, Khella HW, Boulos C, Ibrahim G, Yousef GM.
    Urol Oncol; 2019 Dec 17; 37(12):955-963. PubMed ID: 31635993
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
    Luo Q, Cui M, Deng Q, Liu J.
    Mol Med Rep; 2019 Jun 17; 19(6):4685-4696. PubMed ID: 30957192
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L, Hayashi M, Guida E, Ooki A, Munari E, Jabboure FJ, Dinalankara W, Raza A, Netto GJ, Hoque MO, Argani P.
    Hum Pathol; 2017 Sep 17; 67():18-29. PubMed ID: 28411178
    [Abstract] [Full Text] [Related]

  • 11. hsa-mir-3199-2 and hsa-mir-1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening.
    Luo W, Wang L, Luo MH, Huang YZ, Yang H, Zhou Y, Jia HT, Wang XX.
    J Cell Biochem; 2017 Oct 17; 118(10):3488-3494. PubMed ID: 28338236
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
    Zhan Y, Zhang R, Li C, Xu X, Zhu K, Yang Z, Zheng J, Guo Y.
    Cancer Med; 2021 Sep 17; 10(17):6128-6139. PubMed ID: 34288551
    [Abstract] [Full Text] [Related]

  • 15. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M.
    J Pathol; 2008 Dec 17; 216(4):418-27. PubMed ID: 18925646
    [Abstract] [Full Text] [Related]

  • 16. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.
    Marchini S, Cavalieri D, Fruscio R, Calura E, Garavaglia D, Fuso Nerini I, Mangioni C, Cattoretti G, Clivio L, Beltrame L, Katsaros D, Scarampi L, Menato G, Perego P, Chiorino G, Buda A, Romualdi C, D'Incalci M.
    Lancet Oncol; 2011 Mar 17; 12(3):273-85. PubMed ID: 21345725
    [Abstract] [Full Text] [Related]

  • 17. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.
    Lawrie CH, Armesto M, Fernandez-Mercado M, Arestín M, Manterola L, Goicoechea I, Larrea E, Caffarel MM, Araujo AM, Sole C, Sperga M, Alvarado-Cabrero I, Michal M, Hes O, López JI.
    J Mol Diagn; 2018 Jan 17; 20(1):34-45. PubMed ID: 29056573
    [Abstract] [Full Text] [Related]

  • 18. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
    Khella HW, Bakhet M, Allo G, Jewett MA, Girgis AH, Latif A, Girgis H, Von Both I, Bjarnason GA, Yousef GM.
    Carcinogenesis; 2013 Oct 17; 34(10):2231-9. PubMed ID: 23715501
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R, Khella HW, Scorilas A, Youssef L, Krylov SN, Lianidou E, Sidiropoulos KG, Gabril M, Evans A, Yousef GM.
    Cancer Med; 2016 Apr 17; 5(4):656-64. PubMed ID: 26860079
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.